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Abstract
Background: The liver-derived McNtcp.24 cells transport bile acids and show distinctive
responses to the two classes of conjugated bile acids. Whereas taurine-conjugated bile acids are
non-toxic, glycine-conjugated bile acids efficiently induce apoptosis. The aim of this study was to
determine if the differential sensitivity is limited to cells that normally transport bile acids and if bile
acid binding proteins could reduce bile acid-mediated apoptosis. The apical sodium/bile acid co-
transporter (asbt) was expressed in Chinese hamster ovary (CHO) cells to establish active bile acid
transport in a non-liver-derived cell model (CHO.asbt). A high-affinity bile acid binder was
expressed in McNtcp.24 cells.
Results: The tolerance of McNtcp.24 cells to taurine-conjugated bile acids was associated with the
stimulation of phosphatidylinositol 3-kinase (PI3K) activity. Treatment of CHO.asbt cells with
taurine- and glycine-conjugated bile acids resulted in apoptosis. Unlike in McNtcp.24 cells, PI3K
activity was not increased in CHO.asbt cells treated with taurine-conjugated bile acids. High level
expression of a bile acid binder did not attenuate bile acid-induced cytotoxicity in McNtcp.24 cells.
Conclusion: The data suggest that McNtcp.24 cells possess a mechanism that can elaborate
distinctive responses to the different classes of bile acids. Additionally, activation of a signaling
pathway involving PI3K appears to be the dominant mechanism responsible for the tolerance of
McNtcp.24 cells to taurine-conjugated bile acids.
Introduction
The liver exclusively synthesizes bile acids from choles-
terol via two biosynthetic pathways. The "classical" path-
way begins with the 7α-hydroxylation of cholesterol and
operates entirely in the liver [1]. The "alternative" path-
way begins with the hydroxylation of the cholesterol side
chain. Although this reaction occurs in a wide variety of
cells, the completion of bile acid synthesis takes place in
liver cells. The classical pathway is responsible for the
bulk of the bile acids synthesized by the liver [2,3].
The major bile acid species produced by the liver are
cholic and chenodeoxycholic acids. These bile acids are
conjugated to either taurine or glycine before secretion
into bile [4], which is subsequently released into the
small intestine. Bile acids are reclaimed from the lumen
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for reuse [1]. The recovery of bile acids from the intestine
is an efficient process that involves both passive trans-
port along the entire axis of the intestine, and active
transport in the terminal ileum [5]. The apical sodium/
bile acid co-transporter (asbt) mediates the active uptake
of conjugated bile acids in the ileum [5,6]. In hepato-
cytes, both sodium-dependent and sodium-independent
transport systems on the sinusoidal membranes extract
bile acids from portal blood. Of these, the sodium/bile
acid co-transporting polypeptide (ntcp) is considered to
be quantitatively the most important transporter of con-
jugated bile acids in these cells [7,8]. The transport of
bile acids from the basolateral to the canalicular mem-
brane of liver cells is a poorly understood process. Intra-
cellular bile acid binding proteins have been postulated
to participate in the transcellular transport as well as to
buffer against the cytotoxic effects of bile acids. ATP-de-
pendent transporters on the canalicular membranes of
hepatocytes mediate the secretion of bile acids into bile
[9].
Recently, it was discovered that bile acids are the natural
ligands for a nuclear receptor termed farnesoid x recep-
tor (FXR; NR1H4) [10–12]. Therefore, bile acids may be
important regulators of gene expression in the liver and
intestines. To date, the genes that have been shown to be
responsive to regulation by FXR encode proteins in-
volved in the biosynthesis and transport of bile acids
[13]. Bile acids have been shown to modulate a variety of
other cellular functions, such as secretion of lipoproteins
from hepatocytes [14,15] and translocation of bile acid
transporters to the hepatocyte canalicular membrane
[16]. In McNtcp cells, which are liver-derived cells engi-
neered to transport bile acids actively [17], taurine-con-
jugated bile acids induce the formation of intracellular
vesicles that resembles structures observed in cholestatic
liver cells without apparent cellular cytotoxicity [1,18]. In
contrast, glycine-conjugated bile acids promote apopto-
sis in these cells [19]. Thus, different classes of conjugat-
ed bile acids stimulate distinctive responses in McNtcp
cells. Whereas taurine-conjugated bile acids are well tol-
erated, glycine-conjugated bile acids are extremely cyto-
toxic. Here we examined if this differential response is
limited to cells that normally metabolize bile acids, and
whether high level expression of an intracellular bile acid
binding protein can attenuate the cytotoxic response of
McNtcp.24 cells to glycine-conjugated bile acids.
Results
Differential cytotoxicity of glycine-conjugated bile acids in 
McNtcp.24 cells
We previously showed that taurine-conjugated bile ac-
ids, such as taurocholic (TCA) and taurochenodeoxy-
cholic (TCDCA) acids, were well tolerated by McNtcp.24
cells [18]. In contrast, glycine-conjugated bile acids, such
as glycocholic (GCA) and glycochenodeoxycholic (GCD-
CA) acids, were cytotoxic to McNtcp.24 cells [1] concord-
ant with what has been documented in hepatocytes [19].
Consistent with the induction of apoptotic cell death;
GCDCA, but not TCA, preferentially induced the activa-
tion of the initiator caspase 8 in McNtcp.24 cells (Figure
1A). Indeed, glycine-conjugated bile acids as a class of
molecules induced genomic DNA fragmentation in this
cell line at low concentrations (50 µM), while their tau-
rine counterparts did not (Figure 1B). The cytotoxicity of
glycine-conjugated bile acids cannot be attributed sim-
ply to the preferential cellular accumulation of these bile
acids because McNtcp.24 cells can accumulate GCA and
TCA to similar levels (Torchia and Agellon, unpublished
observations).
There is considerable evidence to suggest that bile acids
activate a variety of cellular signaling pathways in liver
cells [20]. TCDCA is capable of activating PI3K activity in
McNtcp.24 cells and, direct elevation of PI3K activity by
transient expression of a plasmid encoding PI3K can
protect McNtcp.24 cells from GCDCA-induced apoptosis
[21]. TCA, like TCDCA, also caused the elevation of PI3K
activity in McNtcp.24 cells (Figure 2A), suggesting that
activation of PI3K may be a general response to taurine-
conjugated bile acids. Treatment of McNtpc.24 cells with
LY294002, a PI3K inhibitor, prior to the addition of TCA
or TCDCA resulted in the loss of tolerance to these bile
acids as demonstrated by the activation of caspase 8
(Figure 2B). On the other hand, preincubation of Mc-
Ntcp.24 cells with either TCA or TCDCA attenuated the
GCDCA-mediated activation of caspase 8 (Figure 2C),
suggesting that the activation of a PI3K-dependent sur-
vival pathway is dominant over the death pathway. These
results also indicate that the differential sensitivity of the
liver-derived McNtcp.24 cells to conjugated bile acids is
due to the existence of a specific mechanism that is capa-
ble of recognizing different classes of conjugated bile ac-
ids. In these cells, taurine-conjugated bile acids
specifically increase PI3K activity which, in turn, leads to
the activation of a survival pathway [22,23].
Expression of bile acid uptake activity in CHO cells
To determine if non-liver derived cells also posses differ-
ential sensitivity to bile acid-induced cytotoxicity, we en-
gineered CHO cells to take up bile acids actively by
expressing asbt. Colonies surviving the selection process
were assayed for asbt activity and several clones showing
a range of bile acid uptake activities were selected for fur-
ther analysis. Analysis of total RNA from the selected
clones (CHO.asbt) readily showed the presence of the re-
combinant asbt mRNA (Figure 3A). Correspondingly, in
CHO.asbt lysates, an immunoreactive band of compara-
ble size (~45 kDa) to rat asbt protein can be easily detect-
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bile acids by the CHO.asbt cells was saturable with an ap-
parent Km ranging between 22 to 25 µM (Figure 3C). The
Vmax values ranged from 0.323 to 2.769 nmol/mg pro-
tein/min and correlated with the abundance of the re-
combinant asbt mRNA encoded by the transgene. The
uptake of 25 µM TCA by CHO.asbt.8 and CHO.asbt.35
cells reached steady state within 10 min (Figure 3D), im-
plying the presence of a pathway for bile acid efflux in
CHO cells. Furthermore, it was possible to chase the in-
corporated radiolabeled TCA from CHO.asbt.49 and
CHO.asbt.35 cells (Figure 3E). These results demon-
strate that CHO.asbt cells express a fully functional asbt
protein.
Cytotoxic potential of bile acids in CHO.asbt.35 cells
The increase of LDH activity in the culture medium of
CHO.asbt.35 and McNtcp.24 cells after treatment with
glycine- and taurine-conjugated bile acids were com-
pared to assess the cytotoxic potential of bile acids on
these cells. The CHO.asbt.35 cell line was chosen for this
study because this cell line has bile acid uptake activity
that was comparable to McNtcp.24 cells [17]. LDH activ-
ity in the culture medium of McNtcp.24 cells increased
by 20 to 31% within 2 h of incubating the cells in medium
containing 100 µM of glycine conjugates of cholic acid,
chenodeoxycholic acid, and deoxycholic acid (GCA,
GCDCA, GDCA, respectively) (Figure 4A). GCDCA was
the most potent in inducing the release of LDH among
the bile acids tested whereas TCA had little effect as com-
pared to the no addition controls. In contrast, incubation
of CHO.asbt.35 cells in medium containing 100 µM of
taurine- or glycine-conjugated bile acids resulted in a
time dependent increase of LDH activity the culture me-
dium (Figure 4B). GCA and GCDCA were equally potent
in increasing LDH activity, raising the level in the medi-
um of treated cells by 40% within 6 h. Taurine-conjugat-
ed bile acids also raised the LDH activity in the medium
of treated cells to levels approaching GDCA-treated cells
(Figure 4B). Treatment of McArdle RH-7777 and CHO
cells with taurine- or glycine-conjugated bile acids had
little effect on the release of LDH (Figure 4C and 4D), in-
dicating that bile acid uptake activity is necessary to
manifest their cytotoxic potential in both cell lines. In ad-
dition, the cytotoxicity was specific to conjugated bile ac-
ids since the addition of non-conjugated bile acids to the
culture medium of bile acid-transporting cells had a neg-
ligible effect on the release of LDH into the culture medi-
um.
Mechanism of cell death
Members of the caspase family of cysteine proteases
have been implicated in the initiation and execution
phase of apoptosis [24]. In addition, several studies have
shown the activation of the caspase cascade by toxic bile
Figure 1
Differential response of McNtcp.24 cells to bile acid treat-
ment. (A) Cells were treated with bile acids (50 µM) for 1 h,
and caspase 8 activity was assayed in cell extracts using the
fluorogenic substrate, Z-IETD-AFC, as described in the
Materials and Methods. Only GCDCA was able to activate
caspase 8 in McNtpc.24 cells consistent with its role in the
induction of apoptosis. The values shown are mean ± SD (n =
3). (B) Genomic DNA fragmentation in bile acid-treated cells.
The cells were incubated with 50 µM bile acids for 3 h and
genomic DNA was isolated as described in the Materials and
Methods. Glycine-conjugated bile acids induced the DNA
laddering pattern indicative of apoptosis. GCA, glycocholic
acid; GCDCA, glycochenodeoxycholic acid; GDCA, glycode-
oxycholic acid; TCA, taurocholic acid; TCDCA, taurocheno-
deoxycholic acid; TDCA, taurodeoxycholic acid. The
experiments in (A) and (B) were repeated four times with
similar results.
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activity after bile acid treatment in CHO.asbt.35 cells.
Activation of caspase 8 was detected in CHO.asbt.35 cells
after treatment with either taurine- or glycine- conjugat-
ed bile acids (Figure 5A), but absent in bile acid-treated
CHO cells (Figures 5A). Analysis of genomic DNA isolat-
ed from treated cells showed that TCA and GCDCA in-
duced DNA laddering in CHO.asbt.35 cells (Figure 5B),
indicating that both classes of conjugated bile acids in-
duce apoptosis in this non-hepatic derived cell line. To
Figure 2
PI3K activity in bile acid-treated McNtcp.24 cells. (A) Cells were treated with 100 µM bile acid for 1 h and then PI3K activity in
crude membrane fractions were assayed as described in the Materials and Methods. Both TCA and TCDCA stimulated PI3K
activity. (B) Activation of caspase 8 in bile acid-treated McNtcp.24 after pretreatment with 20 µM LY294002. McNtcp.24 cells
were treated with LY294002, a PI3K inhibitor, for 30 min before incubation with 100 µM TCA or TCDCA for 2 h. Note the
loss of tolerance of McNtcp.24 cells to taurine-conjugated bile acids as reflected by the activation of caspase 8 activity (middle
and right bars). (C) McNtcp.24 cells were incubated with TCA or TCDCA for 30 min before incubation with 50 µM GCDCA
for 1 h. Note the attenuation of caspase 8 stimulation when McNtcp.24 cells were exposed to taurine-conjugated bile acids
prior to GCDCA treatment (fourth and last bars). The values shown are means ± SD (n = 3). Differences in comparison to
controls (no addition in (A), (B); GCDC-treated cells in (C)) were evaluated using Student's t-test. *P < 0.05; **P < 0.001. The
experiments in (A), (B), and (C) were repeated three times with similar results.
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Expression of recombinant apical sodium/bile acid transporter (asbt) in CHO cells. (A) The 1.7 kb recombinant asbt mRNA is
readily detectable in total RNA (10 µg) of selected CHO.asbt clones. Note the absence of this band in total RNA of CHO cells.
(B) The recombinant asbt protein is also readily detectable by immunoblotting in total lysates (20 µg) of CHO.asbt cells, but
not of CHO cells. The recombinant asbt protein is similar in size to the authentic asbt detectable in rat ileal cell extracts. (C)
CHO.asbt cells show saturable and concentration dependent uptake of taurocholic acid (TCA). The apparent Km for TCA
range from 22.4 to 25.9 µM. (D) Time dependent uptake of TCA in CHO.asbt and CHO cells. TCA uptake reaches a maxi-
mum at 10 min. (E) Efflux of TCA from CHO.asbt.49 and CHO.asbt.35 cells. The cells were incubated with 25 µM [3H]-TCA
for 20 min to label the intracellular pool of bile acids. The amount of radioactivity that remains associated with the cells after
the removal of radiolabeled TCA from the medium is shown. The values represent means ± SD (n = 3). The experiments in
(A), (B), (C), and (D) were repeated twice with similar results.
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we determined the time course of caspase activation by
bile acids in CHO.asbt.35 and McNtcp.24 cells. Activa-
tion of caspase 8 in both cell lines was first detected by 30
min following GCDCA-treatment and was maximal by
60 min (Figure 6). In contrast, TCA-mediated activation
of caspase 8 was first detected at 60 min and reached the
levels induced by GCDCA by 120 min.
Because the bile acid transporters used to establish bile
acid uptake activity in McNtcp.24 and CHO.asbt.35 cells
were not the same, it was possible that the sensitivity of
CHO.asbt.35 cells to taurine-conjugated bile acids was a
Figure 4
Lactate dehydrogenase (LDH) activity in the medium of bile acid treated cells. McNtcp.24, CHO.asbt.35, McArdle RH-7777,
and CHO cells were incubated in medium supplemented with bile acids (100 µM). (A) Glycine-conjugated bile acids, but not
TCA, induced the time dependent release of LDH in the culture medium of McNtcp.24. (B) Both glycine- and taurine-conju-
gated bile acids induced the release of LDH from CHO.asbt.35 cells. Neither glycine- nor taurine-conjugated bile acids induced
the release of LDH in McArdle RH-7777 (C) or CHO (D) cells after a 5 h incubation. The means ± SD (n = 3) are shown per
time point. These experiments were repeated six times with similar results.
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ity, asbt was expressed in McArdle RH-7777 cells and
then tested for response to glycine- and taurine-conju-
gated bile acids. As shown in Figure 7A, asbt conferred
active bile acid uptake activity in transfected cells. How-
ever, activation of caspase 8 was evident only in the cells
that were treated with GCDCA (Figure 7B). These results
demonstrate that the sensitivity of this cell line to tau-
rine- and glycine-conjugated bile acids is not dependent
on a specific kind of bile acid transporter.
Activation of a PI3K-dependent pathway by taurine-con-
jugated bile acids appears to decide the fate of Mc-
Ntcp.24 cells (Figure 2 and ref. [21]). Therefore, we
determined if PI3K activity was altered in bile acid-treat-
ed CHO.asbt.35 cells. As shown in Figure 8, PI3K activity
in response to TCA or GCDCA was not evident in
CHO.asbt.35 cells, suggesting that the inability to acti-
vate survival pathways by taurine-conjugated bile acids
commit these cells to apoptosis. These findings also indi-
cate that liver derived cells posses a mechanism that re-
sponds to taurine-conjugated bile acids leading to the
activation of PI3K.
Figure 5
Apoptosis in bile acid-treated CHO.asbt.35 cells. (A) Cells
were treated with various bile acids (100 µM) for 2 h, and
then caspase 8 activity was assayed in cellular extracts using
the caspase 8 fluorogenic substrate, Z-IETD-AFC. Both gly-
cine- and taurine-conjugated bile acids induced the activation
of caspase 8 in CHO.asbt.35 cells (dark bars), but not in
CHO cells (white bars). Caspase 8 activity in GCDCA-
treated cells inhibited in vitro by addition of the caspase 8
inhibitor Ac-IETD-cho to the cell extracts (right most bar,
panel A). The basal level of caspase 8 activity in untreated
cells is also shown by the (left most pair of bars, panel A).
The values shown are mean ± SD (n = 3) and are representa-
tive of several experiments. (B) Fragmentation of genomic
DNA in bile acid-treated CHO.asbt.35 cells. The cells were
incubated with 50 µM taurine- or glycine-conjugated bile
acids for 3 h. Both classes of conjugated bile acids induced
DNA laddering in CHO.asbt.35 cells. Original magnification
= 400X. These experiments were repeated three times with
similar results.
Figure 6
Time dependent activation of caspase 8 in bile acid-treated
CHO.asbt.35 and McNtcp.24 cells. Cells were treated with
50 µM bile acids. After a time interval, cellular extracts were
isolated and assayed for caspase 8 activity. The means ± SD
(n = 3) are shown for each time point. This experiment was
repeated twice with similar results.
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Ntcp.24 cells
It has been suggested that sequestration of bile acids by
intracellular bile acid binding proteins may also protect
cells from bile acid cytotoxicity. Thus, the human bile
acid binder (HBAB) was expressed in McNtcp.24 cells to
determine if this class of proteins can protect against
GCDCA cytotoxicity. Figure 9A shows the presence of the
recombinant mRNA encoding the recombinant HBAB in
clones that have incorporated the HBAB expression vec-
tor into their genomes. In addition, the HBAB protein
abundance in the total lysates correlated with the abun-
dance of the HBAB mRNA (Figure 9A). Analysis of radi-
olabeled TCA uptake (Figure 9B) showed that expression
of HBAB had minimal impact on bile acid uptake despite
the fact that the range of HBAB protein abundance was
up to 5-fold greater than that in the lowest HBAB ex-
pressing cell. Moreover, the rates of decline in the
amount of radiolabeled TCA associated with the cells af-
ter withdrawal of the radiolabeled bile acids from the cul-
ture medium was comparable among the different clones
(Figure 9C), indicating that the rate of bile acid efflux
from these cells was also not affected by the presence of
HBAB.
Incubation of the BN clones with GCDCA increased the
LDH activity in the culture medium to a level similar to
that in the medium of GCDCA-treated McNtcp.24 cells
(Figure 10A). In addition, caspase 8 activity in bile acid-
treated BN.25, BN.46 and BN.49 was comparable to that
in McNtcp.24, which were elevated compared to that in
McArdle RH-7777 cells (Figure 10B). The time course of
Figure 7
Expression of asbt in McArdle RH-7777 cells and induction of
caspase 8 activity. (A) Uptake of TCA was enhanced in
McArdle RH-7777 cells expressing asbt. (B) Treatment of
asbt- expressing McArdle RH-7777 with GCDCA (right bar),
but not with TCA (middle bar), showed activation of caspase
8 activity. The values shown are mean ± SD (n = 6). Differ-
ences in comparison to controls were evaluated using a Stu-
dent's t test. *P < 0.05. The experiment in (A) was repeated
twice and the experiment in (B) was repeated three times
with similar results.
Figure 8
PI3K activity in bile acid-treated CHO.asbt.35 cells. Cells
were treated as detailed in Figure 2 and PI3K activity in crude
membrane fractions was assayed as described in Materials
and Methods. In CHO.asbt.35 cells, neither TCA nor
GCDCA have an effect on PI3K activity. The values shown
are means ± SD (n = 3). This experiment was repeated twice
with similar results.
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µM bile acids was similar to that observed for McNtcp.24
cells (Figure 10C). Therefore, the presence of an intracel-
lular bile acid binding protein did not protect these cells
from glycine-conjugated bile acid cytotoxicity, even at
low bile acid concentrations. These results indicate that
the activation of a signaling cascade involving PI3K is the
dominant mechanism responsible for protecting Mc-
Ntcp.24 cells from the cytotoxicity of glycine-conjugated
bile acids.
Discussion
In this study, we determined if the differential sensitivity
elaborated by the liver-derived McNtcp.24 cell line to
different classes of conjugated bile acids is limited to
cells that normally transport bile acids. We previously
demonstrated that taurine-conjugated bile acids are not
toxic to McNtcp.24 cells [18]. In contrast, glycine-conju-
gated bile acids induce apoptosis in McNtcp.24 cells and
primary mouse hepatocytes, through activation of the
Fas receptor in a FasL-independent manner [19,25].
Moreover, GCDCA was demonstrated to activate both in-
itiator and effector caspases, and that the apoptotic re-
sponse can be blocked by Crm A, a caspase 8 inhibitor
[25]. The mechanism by which bile acids stimulate the
activation of Fas receptor remains unclear. In Fas defi-
cient hepatocytes, toxic bile acids were still able to induce
apoptosis, suggesting that bile acids are capable of stim-
ulating multiple pathways to initiate cell death [26].
To gain further insight into the specificity of bile acid cy-
totoxicity, we conferred active bile acid uptake capacity
in CHO cells, a cell type that does not normally metabo-
lize bile acids, by expressing a bile acid transporter.
CHO.asbt cells produce recombinant asbt with a molec-
ular mass and kinetic parameters that are similar to pre-
viously reported values [6]. It is not known if CHO cells
have pathways capable of facilitating the efflux of bile ac-
ids out of the cell. The apparent efflux observed in
CHO.asbt.35 could be attributed to the fact that asbt is
capable a bidirectional transport of bile acids [27]. How-
ever, it is conceivable that an efflux mechanism that rec-
ognizes bile acids exists in CHO cells and other
mammalian cells. Indeed, yeast and plants express pro-
teins capable of active bile acid transport [28]. As these
organisms do not normally synthesize bile acids, their
ability to transport bile acids may illustrate a generalized
mechanism for cellular transport of hydrophobic organic
anions.
CHO.asbt.35 cells were used as a model to assess the cy-
totoxic potential of taurine- and glycine-conjugated bile
acids in non-hepatic derived and non-bile acid metabo-
lizing cells. Unlike McNtcp.24 cells, treatment of
CHO.asbt clones with taurine-conjugated bile acids re-
Figure 9
Expression of the human bile acid binder (HBAB) in
McNtcp.24 cells and transport of bile acids in HBAB-express-
ing McNtcp.24 cells (BN cells). (A) The 2.0 kb recombinant
HBAB mRNA is readily detectable in total RNA (10 µg) of
selected BN clones. Note the absence of the recombinant
HBAB mRNA in McNtcp.24 cells. The blot was stripped and
reprobed with the mouse glyceraldehyde-3-phoshate dehy-
drogenase (G3PDH) cDNA to demonstrate the presence of
mRNA in the samples analyzed. The recombinant HBAB pro-
tein is also readily detectable by immunoblotting in total
lysates (20 µg) of BN and McNtcp.24 cells. The α-actin
antiserum was used to demonstrate equivalent amounts of
total proteins analyzed. (B) TCA uptake activity of the BN
clones and McNtcp.24 cells are shown. The values are rela-
tive to the TCA uptake activity of McNtcp.24 cells (100 %).
(C) Efflux of TCA from BN clones and McNtcp.24 cells. The
cells were incubated with 25 µM [3H]-TCA for 20 min to
label the intracellular pool of bile acids. The amount of radio-
activity that remains associated with the cells after the
removal of radiolabeled TCA from the medium is shown.
The values represent means ± SD (n = 3). The slopes of the
regression lines were compared by analysis of variance and
no statistical differences were found. The experiments in (A)
and (C) were repeated twice and the experiment in (B) was
repeated three times with similar results.
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conjugated bile acid tested. It is unlikely that the ob-
served cytotoxicity of the conjugated bile acids could be
attributed to the generalized intracellular accumulation
of bile acids because unconjugated bile acids were trans-
ported by CHO.asbt cells but did not cause significant re-
lease of LDH into the culture medium (Torchia and
Agellon, unpublished observations). In contrast, glycine-
conjugated bile acids (GCDCA in particular) were highly
effective at causing the increase in LDH activity in the
culture medium of both McNtcp.24 and CHO.asbt.35
cells. Primary hepatocytes exhibit differential sensitivity
to taurine- and glycine-conjugated bile acids in culture
[29]. The bile acid-transporting WIF-B cells, which are
rat hepatoma-human fibroblast hybrids [30], remain vi-
able even when grown in TCA-containing culture medi-
um for up to 14 days [31]. In contrast, our study shows
that taurine-conjugated bile acids is toxic to a cell type
that is not normally exposed to bile acids. Liver cells,
which normally metabolize bile acids, apparently pos-
sess a mechanism that can distinguish and differentially
elaborate distinct biological activities of taurine- and gly-
cine-conjugated bile acids.
Both taurine- and glycine-conjugated bile acids induce
apoptotic cell death in CHO.asbt.35 cells. The involve-
ment of the caspase cascade in CHO.asbt.35 cells was il-
lustrated by the fact that conjugated bile acids activated
caspase 8 in a time dependent manner. However, the dif-
ferent profile of caspase 8 activation suggests that tau-
rine- and glycine-conjugated bile acids may trigger
apoptosis by different pathways. At present, it is not
known how conjugated bile acids activate caspases in
CHO.asbt.35 cells. A protein that is immunoreactive to a
Fas receptor antiserum and has a molecular mass similar
to the rat Fas receptor is detectable in CHO cell extracts
(Torchia and Agellon, unpublished results). This leaves
the possibility that conjugated bile acids may activate the
apoptotic cascade through Fas receptor in this cell line,
as glycine-conjugated bile acids do in hepatocytes [25].
However, the activation of caspases does not require a
specific kind of bile acid transporter since TCA is not tox-
ic to McArdle RH-7777 cells irrespective of whether these
cells internalize bile acids via ntcp or asbt.
The differential response of McNtcp.24 cells to different
classes of conjugated bile acids is apparently due to the
selective activation of either a PI3K-dependent survival
pathway [22,23] or caspase-dependent death pathway
[32]. Indeed, neither taurine- nor glycine-conjugated
bile acids stimulated PI3K activity in CHO.asbt.35 cells
and both classes of bile acids were toxic. In addition, pre-
treatment of McNtcp.24 cells with a PI3K inhibitor ren-
dered these cells susceptible to TCA- and TCDCA- medi-
ated cell death. The latter finding indicates that taurine-
Figure 10
Sensitivity of BN cells to GCDCA treatment. The cytotoxic
potential of GCDCA in BN and McNtcp.24 cells was
assessed by measuring LDH release and caspase 8 activity.
(A) LDH activity in the medium of cells treated with 100 µM
GCDCA for 4 h. The values are relative to the LDH activity
in the medium of GCDCA-treated McNtcp.24 cells (100 %).
(B, C) Cells were treated with 50 µM GCDCA for 1 h and
with 10 µM for 2 and 4 h. Caspase 8 activity was then
assayed in cellular extracts. The values represent means ± SD
(n = 3). The experiment in (A) was repeated three times and
the experiments in (B) and (C) were repeated twice with
similar results.
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when PI3K is inhibited, probably by utilizing the same
mechanism activated by glycine-conjugated bile acids.
That TCA is able to activate PI3K in plasma membrane
fractions from McNtpc.24 agrees with a previous study
showing that TCA increases PI3K activity in canalicular
and sinusoidal membrane vesicles [16]. The activation of
PI3K in that report was also associated with recruitment
of sister of P-glycoprotein (the bile acid export pump)
and other multidrug resistance proteins to the canalicu-
lar membrane [16]. Extended treatment of McNtcp.24
cells does not appear to have detrimental and permanent
consequences on cellular function. The marked morpho-
logical changes that occur during long term incubation
with TCA [18] dissipate after the withdrawal of the bile
acid from the culture medium, and the cells remain via-
ble.
The significance of an intracellular and high affinity bile
acid binder in bile acid mediated cytotoxicity was also
evaluated. Several proteins capable of binding bile acids
in vitro have been identified (reviewed in ref. [1]). It is
thought that the major bile acid binding protein in the
cytosol of rat hepatocytes is 3α-hydroxysteroid dehydro-
genase, a member of the aldo keto reductase supergene
family [33]. However, the exact role of this protein in in-
tracellular transport of bile acids and cytoprotection was
undefined. HBAB, a member of the human aldo keto re-
ductase gene family, has been shown to bind bile acids
with high affinity (<1 µM) and is postulated to play a sim-
ilar role as 3α-hydroxysteroid dehydrogenase in human
hepatocytes [33]. Expression of HBAB in McNtcp.24
cells was expected to increase the capacity of these cells
to sequester bile acids in the cytoplasm, and thereby re-
duce their toxicity. High level expression of HBAB had a
negligible effect on the ability of the BN clones to take up
or secrete bile acids, suggesting that HBAB has a minor
role in the net transport of bile acids in these cells. More
importantly however, expression of HBAB in McNtcp.24
cells had no effect on GCDCA-induced cell death, even at
low bile acid concentrations, indicating that this class of
protein does not provide cytoprotection against toxic bile
acids as previously suspected. This finding is consistent
with the idea that bile acids directly modulate specific
signaling cascades that control cellular death and surviv-
al.
In summary, the failure of CHO.asbt cells to tolerate tau-
rine-conjugated bile acids has revealed the existence of a
mechanism that may be specific for cells that normally
metabolize bile acids. Since bile acids undergo enterohe-
patic circulation, it would be reasonable to expect the ex-
istence of the same mechanism in other cell types that
naturally transport bile acids, such as ileocytes and
cholangiocytes [34,35]. The last few years have brought
significant advances in our understanding of bile acid
transport in liver and intestinal cells. However, the regu-
latory potential of bile acids is only beginning to be real-
ized. With the recent discovery that bile acids represent
the natural ligands for the nuclear receptor FXR [10–12],
there is heightened interest in identifying the genes that
are regulated by bile acids. Insight into how bile acids di-
rectly modulate a variety of other cellular functions will
be important in understanding the significance of cellu-
lar responses to bile acids.
Materials and Methods
Materials
Tissue culture reagents were purchased from Canadian
Life Technologies (Burlington, ON, Canada). [3H]-Tau-
rocholic acid (2.6 Ci/mmol), [32P]-dCTP (3000 Ci/
mmol), and [32P]-ATP (3000 Ci/mmol) were purchased
from Amersham Pharmacia Biotech (Baie d'Urfe, QC,
Canada). Bile acids were obtained from Sigma-Aldrich
Canada Ltd. (Oakville, ON, Canada) and Calbiochem-
NovaBiochem Corp. (San Diego, CA, USA). Other rea-
gents purchased from various commercial suppliers
were of analytical grade.
Cell lines
McNtcp.24 cells were cultured as described previously
[17]. Chinese hamster ovary K1 cells were cultured in
Ham's F12 medium supplemented with 10% fetal bovine
serum. To establish cell lines stably expressing asbt, a
cDNA encoding the hamster asbt [36] was cloned into
pBK-CMV expression vector (Stratagene, La Jolla, CA).
The prokaryotic promoter embedded in the 5'-untrans-
lated region of the encoded recombinant eukaryotic
mRNA was removed from the resulting plasmid. The hu-
man bile acid binder (HBAB) cDNA [37] was cloned into
a derivative of pCep4 (Invitrogen Corp., Carlsbad, CA),
that had been previously modified by deleting the EBNA
1 gene [38]. The lipofectamine reagent (Canadian Life
Technologies) was used to transfect the expression plas-
mid into CHO, McArdle RH7777, and McNtcp.24 cells.
The cell medium was replaced 24 h post-transfection
with medium containing G418 (400 µg/ml) or hygromy-
cin (500 µg/ml) to select for stable transfectants. Surviv-
ing colonies were expanded and assayed for the ability to
take up [3H]-TCA from the culture medium as described
previously [17] or assayed for the expression of HBAB by
immunoblotting.
RNA and immunoblot analyses
Total RNA from CHO.asbt and BN cells was prepared
and analyzed by RNA blotting as previously described
[17]. Cell lysates were prepared by lysing cells in 50 mM
Tris-HCl (pH 7.4), 1% NP-40%, 0.25% sodium deoxy-
cholate; 150 mM NaCl, 1 mM EGTA, 1 mM Na3VO4, 1
mM sodium fluoride, containing a protease inhibitor
BMC Biochemistry 2001, 2:11 http://www.biomedcentral.com/1471-2091/2/11cocktail (Sigma-Aldrich Canada Ltd.). The lysates were
fractionated by polyacrylamide gel electrophoresis and
then transferred to Immobilon-P membrane (Millipore
Ltd., Nepean, ON). Asbt was detected using a rabbit an-
tiserum directed against the last 14 amino acids of the
carboxyl terminal of the hamster asbt protein. HBAB
protein was detected as previously described [37].
Bile acid uptake activity assay
Uptake studies in CHO.asbt, BN and McNtcp.24 cells
were done as previously described [17]. Protein content
was determined using the Bradford method [39] with bo-
vine serum albumin as the standard.
Lactate dehydrogenase (LDH) assay
Cells (104 per well) were grown on 24 well multiwell
plates for 16 h. The cells were then washed with phos-
phate buffered saline (PBS) and then incubated in medi-
um (Ham's F12 or Dulbecco's modified Eagle's medium
(DMEM)) containing 100 µM bile acids for 1 to 5 h as de-
tailed in the Figure legends. The media was collected and
adjusted to 0.1% Triton X-100. Cells remaining on the
dish were dissolved in medium (Ham's F12 or DMEM)
containing 0.1% Triton X-100. LDH activities in both the
cell lysates and media were measured as described previ-
ously [40].
Visualization of genomic DNA fragmentation
Cells (106 per 60 mm dish) were grown for 16 h. After
washing with PBS, the cells were incubated with 50 µM
bile acids for 3 h at 37°C. Adherent and non-adherent
cells were dissolved in Tris-buffered saline (pH 7.6) con-
taining 10 mM EDTA and 0.5% sarkosyl, and 1 mg/ml
proteinase K. After digestion (~16 h) of cellular proteins
at 55°C, DNA was sequentially extracted with phenol/
chloroform and chloroform. The DNA was precipitated,
washed in 70% ethanol, and dissolved in buffer contain-
ing 10 mM Tris-HCL (pH 7.5) and 1 mM EDTA. The iso-
lated DNA was treated with RNase A and then analyzed
by conventional agarose gel electrophoresis [41]. DNA
was visualized with ultraviolet light after ethidium bro-
mide staining.
Caspase activity assays
Cells (106 per 60 mm dish) were grown for 16 h. After
washing with PBS, the cells were incubated with 50 to
100 µM bile acids for 1 to 2 h. After the incubation period,
the medium was discarded and adherent cells were har-
vested in PBS and sedimented by centrifugation (500 ×
g). The cells were resuspended in buffer containing 50
mM Tris-HCl (pH 7.5), 1% Nonidet P-40, and 150 mM
NaCl. Following 10 min incubation on ice, lysed cells
were centrifuged for 10 min, 10,000 × g at 4°C. The su-
pernatant was assayed for caspase activity in 20 mM Pip-
erazine-N,N'-bis(2-ethanesulfonic acid) (pH 6.8), 100
mM NaCl, 1 mM EDTA, 1% CHAPS, and 10% sucrose
with Z-IETD-AFC for caspase 8 [42,43]. The release of
the fluorogenic-leaving group was detected by excitation
at 400 nm and emission at 505 nm. Free AFC was used
to generate standard curve.
PI3K activity assay
Crude membrane fractions were isolated from CHO.asbt
and McNtcp.24 cells as described previously [44]. To
prepare lipid suspension, phosphatidylserine and phos-
phatidylinositol (1:1) were sonicated in 25 mM 3-(N-
morpholino)propanesulfonic acid (MOPS; pH 7.0), 1
mM EGTA, 1 mM Na3VO4. Cell extracts were assayed in
25 mM MOPS (pH 7.5), 5 mM MgCl2, 1 mM EGTA, 1 mM
Na3VO4, 130 µM ATP, 20 µCi [32P]-ATP (3000 Ci/
mmol) and 0.2 mg/ml sonicated lipids. The reaction was
allowed to proceed for 10 min at 37°C and stopped by ad-
dition of 300 µl of 1N HCl:methanol (1:1). Lipids were ex-
tracted twice with 350 µl chloroform and the organic
phases from both extractions were combined then
washed once with 700 µl 1 N HCl/methanol (1:1). Lipids
were dried, and then taken up in chloroform:methanol
(1:1). The samples were spotted along with pure phosph-
oinositol phosphate standards (Avanti Polar Lipids, Ala-
baster, AL, USA) onto 1.2% potassium oxalate
impregnated TLC plates [45]. The chromatogram was
developed in chloroform: methanol: water: aqueous am-
monia (90:70:17:3) [46]. The incorporation of [32P] into
phosphatidylinositol was quantitated by phosphorimag-
ing using a Fuji BAS1000 phosphorimager. Visualization
of standards was done by dippingTLC plates in 10%
CuSO4,10% H3PO4 and heating at 200°C for 10 min.
Statistical analysis
Each set of experiments was repeated at least twice. The
data is represented by means ± SD. Differences between
control and test cells were evaluated by a Student's t test.
Differences in the slope of regression lines were evaluat-
ed by analysis of variance. P values of <0.05 were consid-
ered statistically significant.
List of abbreviations used
asbt, apical sodium/bile acid cotransporter; GCA, glyco-
cholic acid; GCDCA, glycochenodeoxycholic acid; HBAB,
human bile acid binder; LDH, lactate dehydrogenase;
PI3K, phosphatidylinositol 3-kinase; TCA, taurocholic
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